Sandra Anaya-O’Brien

发表

Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.

M. Raffeld, S. Holland, J. Moss, 2008, American journal of respiratory and critical care medicine.

AMD3100 is a potent antagonist at CXCR4R334X, a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome

D. McDermott, H. Malech, P. Murphy, 2011, Journal of cellular and molecular medicine.

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.

T. Fleisher, D. Kuhns, D. McDermott, 2011, Blood.

CXCR4/IgG-expressing plasma cells are associated with human gastrointestinal tissue inflammation.

T. Chun, A. Fauci, J. Kovacs, 2014, The Journal of allergy and clinical immunology.

WHIM Syndrome Caused by Waldenström’s Macroglobulinemia-Associated Mutation CXCR4L329fs

D. McDermott, H. Malech, P. Murphy, 2016, Journal of Clinical Immunology.

WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4.

D. Wechsler, D. McDermott, H. Malech, 2012, Blood.

Gastrointestinal involvement in chronic granulomatous disease.

S. Holland, D. Kleiner, S. Rosenzweig, 2004, Pediatrics.

WHIM Syndrome Caused by Waldenström’s Macroglobulinemia-Associated Mutation CXCR4L329fs

D. McDermott, H. Malech, P. Murphy, 2016, Journal of Clinical Immunology.

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor.

S. Pittaluga, T. Fleisher, D. Kuhns, 2014, Blood.

Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency

L. Notarangelo, J. Gray, D. Kuhns, 2016, Science Translational Medicine.

The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome.

T. Fleisher, D. Kuhns, H. Malech, 2011, Blood.

Gastrointestinal involvement in chronic granulomatous disease.

S. Rosenzweig, V. Anderson, D. Darnell, 2004, Pediatrics.